Anakinra inhibits IL-1 and by that the NF-κB pathway, reducing proliferation, migration, and invasion of PDAC cells, and IL-1 neutralization sensitizes cancer cells for immunotherapy and chemotherapy (40, 46). The gene discussed is IL1B; the disease is cancer.